Cargando…

DNAH7 mutations benefit colorectal cancer patients receiving immune checkpoint inhibitors

BACKGROUND: Colorectal cancer (CRC) is a malignant tumor associated with a high mortality rate. While the advent of immune checkpoint inhibitors (ICIs) has been a gamechanger, only a small percentage of CRC patients benefit from ICIs. The pathological mechanism of CRC is not well understood, but som...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Wenjuan, Shen, Zhengjie, Yang, Ti, Wu, Mianhua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9843387/ https://www.ncbi.nlm.nih.gov/pubmed/36660654 http://dx.doi.org/10.21037/atm-22-6166

Ejemplares similares

Novel homozygous mutations of DNAH5 in Kartagener syndrome
por: Cheng, Xian-Dong, et al.
Publicado: (2021)

Co-occurrence of Moyamoya syndrome and Kartagener syndrome caused by the mutation of DNAH5 and DNAH11: a case report
por: Zhang, Lili, et al.
Publicado: (2020)

Multiomics Analysis of a DNAH5-Mutated PCD Organoid Model Revealed the Key Role of the TGF-β/BMP and Notch Pathways in Epithelial Differentiation and the Immune Response in DNAH5-Mutated Patients
por: Yang, Wenhao, et al.
Publicado: (2022)

A Japanese Case of Primary Ciliary Dyskinesia with DNAH5 Mutations
por: Orimo, Mami, et al.
Publicado: (2019)

DNAH10 mutation correlates with cisplatin sensitivity and tumor mutation burden in small-cell lung cancer
por: Li, Man, et al.
Publicado: (2020)

A novel frameshift mutation in DNAH6 associated with male infertility and asthenoteratozoospermia
por: Huang, Fei, et al.
Publicado: (2023)

PTCH1 mutation promotes antitumor immunity and the response to immune checkpoint inhibitors in colorectal cancer patients
por: Wang, Yanni, et al.
Publicado: (2021)

EPHA7 mutation as a predictive biomarker for immune checkpoint inhibitors in multiple cancers
por: Zhang, Zhen, et al.
Publicado: (2021)

Somatic mutation of DNAH genes implicated higher chemotherapy response rate in gastric adenocarcinoma patients
por: Zhu, Chunchao, et al.
Publicado: (2019)

Mutated processes predict immune checkpoint inhibitor therapy benefit in metastatic melanoma
por: Patterson, Andrew, et al.
Publicado: (2022)

Catenin Alpha-2 Mutation Changes the Immune Microenvironment in Lung Adenocarcinoma Patients Receiving Immune Checkpoint Inhibitors
por: Wen, Yang, et al.
Publicado: (2021)

Cutaneous immune-related adverse events among Taiwanese cancer patients receiving immune checkpoint inhibitors link to a survival benefit
por: Cho, Yung-Tsu, et al.
Publicado: (2022)

Identification of DNAH6 mutations in infertile men with multiple morphological abnormalities of the sperm flagella
por: Tu, Chaofeng, et al.
Publicado: (2019)

Novel variants in DNAH9 lead to nonsyndromic severe asthenozoospermia
por: Tang, Dongdong, et al.
Publicado: (2021)

Bioinformatics analysis to identify action targets in NCI-N87 gastric cancer cells exposed to quercetin
por: Zeng, Yun, et al.
Publicado: (2018)

Novel Loss-of-Function Mutations in DNAH1 Displayed Different Phenotypic Spectrum in Humans and Mice
por: Khan, Ranjha, et al.
Publicado: (2021)

Two novel mutations in the DNAH11 gene in primary ciliary dyskinesia (CILD7) with considerable variety in the clinical and beating cilia phenotype
por: Schultz, Rüdiger, et al.
Publicado: (2020)

Author Correction: Mutated processes predict immune checkpoint inhibitor therapy benefit in metastatic melanoma
por: Patterson, Andrew, et al.
Publicado: (2023)

Thrombocytopenia in patients with melanoma receiving immune checkpoint inhibitor therapy
por: Shiuan, Eileen, et al.
Publicado: (2017)

Follow-up Care for Patients Receiving Immune Checkpoint Inhibitors
por: Zhang, Liyan, et al.
Publicado: (2021)

Corneal Transplant Rejections in Patients Receiving Immune Checkpoint Inhibitors
por: Moshirfar, Majid, et al.
Publicado: (2022)

Biomarkers for immune checkpoint inhibitors in colorectal cancer: recent advances and future perspectives
por: Yang, Changjiang, et al.
Publicado: (2023)

ATM Mutations Benefit Bladder Cancer Patients Treated With Immune Checkpoint Inhibitors by Acting on the Tumor Immune Microenvironment
por: Yi, Ruibin, et al.
Publicado: (2020)

Variation in DNAH1 may contribute to primary ciliary dyskinesia
por: Imtiaz, Faiqa, et al.
Publicado: (2015)

Novel bi-allelic mutations in DNAH1 cause multiple morphological abnormalities of the sperm flagella resulting in male infertility
por: Jiang, Chuan, et al.
Publicado: (2021)

Somatic mutations in genes associated with mismatch repair predict survival in patients with metastatic cancer receiving immune checkpoint inhibitors
por: Liu, Yongping, et al.
Publicado: (2020)

DNAH11 compound heterozygous variants cause heterotaxy and congenital heart disease
por: Xia, Hong, et al.
Publicado: (2021)

Novel DNAH1 Mutation Loci Lead to Multiple Morphological Abnormalities of the Sperm Flagella and Literature Review
por: Zhuang, Bao-Jun, et al.
Publicado: (2022)

A DNAH17 missense variant causes flagella destabilization and asthenozoospermia
por: Zhang, Beibei, et al.
Publicado: (2019)

Nomogram to predict the outcomes of patients with microsatellite instability-high metastatic colorectal cancer receiving immune checkpoint inhibitors
por: Pietrantonio, Filippo, et al.
Publicado: (2021)

Systemic immune parameters after prior radiation therapy in patients receiving immune checkpoint inhibitors
por: Mundra, Vatsala, et al.
Publicado: (2023)

Recessive DNAH9 Loss-of-Function Mutations Cause Laterality Defects and Subtle Respiratory Ciliary-Beating Defects
por: Loges, Niki T., et al.
Publicado: (2018)

Prognostic impact of sarcopenia on immune-related adverse events in malignancies received immune checkpoint inhibitors: a systematic review and meta-analysis
por: Li, Shuluan, et al.
Publicado: (2021)

Identification and validation of a prognostic-related mutant gene DNAH5 for hepatocellular carcinoma
por: Song, Zebing, et al.
Publicado: (2023)

Influenza vaccination and myocarditis among patients receiving immune checkpoint inhibitors
por: Awadalla, Magid, et al.
Publicado: (2019)

QUALITY OF LIFE IN OLDER ADULTS RECEIVING IMMUNE CHECKPOINT INHIBITOR THERAPY
por: Hoogland, Aasha I, et al.
Publicado: (2019)

Risk of COVID‐19 in Patients with Cancer Receiving Immune Checkpoint Inhibitors
por: Klebanov, Nikolai, et al.
Publicado: (2021)

Cytomegalovirus infection among patients with cancer receiving immune checkpoint inhibitors
por: Panneerselvam, Kavea, et al.
Publicado: (2022)

Clostridioides difficile infection in cancer patients receiving immune checkpoint inhibitors
por: Vasavada, Shaleen, et al.
Publicado: (2022)

Assessing the risk of cardiovascular events in patients receiving immune checkpoint inhibitors
por: Torrente, María, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_alp5u37tgh7mnr8bfgmtuiv3c8